BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 28212562)

  • 1. Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6.
    Xi Z; Wang P; Xue Y; Shang C; Liu X; Ma J; Li Z; Li Z; Bao M; Liu Y
    Oncotarget; 2017 Apr; 8(15):24949-24963. PubMed ID: 28212562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway.
    Yang Y; Dodbele S; Park T; Glass R; Bhat K; Sulman EP; Zhang Y; Abounader R
    J Neurooncol; 2019 Oct; 145(1):23-34. PubMed ID: 31482267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of NEAT1 restrained the malignant progression of glioma stem cells by activating microRNA let-7e.
    Gong W; Zheng J; Liu X; Ma J; Liu Y; Xue Y
    Oncotarget; 2016 Sep; 7(38):62208-62223. PubMed ID: 27556696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122.
    Su R; Cao S; Ma J; Liu Y; Liu X; Zheng J; Chen J; Liu L; Cai H; Li Z; Zhao L; He Q; Xue Y
    Mol Cancer; 2017 Nov; 16(1):171. PubMed ID: 29132362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
    Wang Z; Xue Y; Wang P; Zhu J; Ma J
    Oncol Rep; 2016 May; 35(5):2733-42. PubMed ID: 26935642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
    Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-152 functions as a tumor suppressor in glioblastoma stem cells by targeting Krüppel-like factor 4.
    Ma J; Yao Y; Wang P; Liu Y; Zhao L; Li Z; Li Z; Xue Y
    Cancer Lett; 2014 Dec; 355(1):85-95. PubMed ID: 25218589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.
    Zheng J; Li XD; Wang P; Liu XB; Xue YX; Hu Y; Li Z; Li ZQ; Wang ZH; Liu YH
    Oncotarget; 2015 Sep; 6(28):25339-55. PubMed ID: 26231038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
    Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
    Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
    Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
    Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR-152.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Liu J; Chen L; Xi Z; Teng H; Wang Z; Li Z; Liu Y
    Cancer Lett; 2015 Apr; 359(1):75-86. PubMed ID: 25578780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of miR16 in glioblastoma and glioblastoma stem cells: their correlation with proliferation, differentiation, metastasis and prognosis.
    Tian R; Wang J; Yan H; Wu J; Xu Q; Zhan X; Gui Z; Ding M; He J
    Oncogene; 2017 Oct; 36(42):5861-5873. PubMed ID: 28628119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-330-mediated regulation of SH3GL2 expression enhances malignant behaviors of glioblastoma stem cells by activating ERK and PI3K/AKT signaling pathways.
    Yao Y; Xue Y; Ma J; Shang C; Wang P; Liu L; Liu W; Li Z; Qu S; Li Z; Liu Y
    PLoS One; 2014; 9(4):e95060. PubMed ID: 24736727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-449a exerts tumor-suppressive functions in human glioblastoma by targeting Myc-associated zinc-finger protein.
    Yao Y; Ma J; Xue Y; Wang P; Li Z; Li Z; Hu Y; Shang X; Liu Y
    Mol Oncol; 2015 Mar; 9(3):640-56. PubMed ID: 25487955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-29a-Mediated CD133 Expression Contributes to Cisplatin Resistance in CD133
    Yang L; Li N; Yan Z; Li C; Zhao Z
    J Mol Neurosci; 2018 Nov; 66(3):369-377. PubMed ID: 30267383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.
    Shi L; Wang Z; Sun G; Wan Y; Guo J; Fu X
    Neuromolecular Med; 2014 Jun; 16(2):517-28. PubMed ID: 24777293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-146b-5p suppresses the malignancy of GSC/MSC fusion cells by targeting SMARCA5.
    Wang H; Tan L; Dong X; Liu L; Jiang Q; Li H; Shi J; Yang X; Dai X; Qian Z; Dong J
    Aging (Albany NY); 2020 Jul; 12(13):13647-13667. PubMed ID: 32632040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface GRP78 regulates BACE2 via lysosome-dependent manner to maintain mesenchymal phenotype of glioma stem cells.
    Chen Z; Wang H; Zhang Z; Xu J; Qi Y; Xue H; Gao Z; Zhao R; Wang S; Zhang S; Qiu W; Guo X; Li G
    J Exp Clin Cancer Res; 2021 Jan; 40(1):20. PubMed ID: 33413577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pterostilbene suppressed irradiation-resistant glioma stem cells by modulating GRP78/miR-205 axis.
    Huynh TT; Lin CM; Lee WH; Wu AT; Lin YK; Lin YF; Yeh CT; Wang LS
    J Nutr Biochem; 2015 May; 26(5):466-75. PubMed ID: 25736407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
    Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
    Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.